ANSWER: Malarone is one of the first-line choices to prevent malaria in areas with and without resistance to other drugs. It is safe and effective for most people. The itchiness your wife experienced ...

Dear Anon.: Malarone is one of the first-line choices to prevent malaria in areas with and without resistance to other drugs.

Researchers described a new skin disease in a male patient with erythroderma, causing 80 percent of his skin to be covered with red, exfoliating skin lesions that itched and burned. After undergoing ...

The body contains several nerve endings that cause itching ... Managing itching with cancer is essential in improving your quality of life, especially when itching is severe, such as with liver ...

Journavx is the first of a new class of non-opioid pain medications FDA-approved for treating moderate-to-severe acute pain in adults. A new medication is on the horizon for adults dealing with acute ...

It is now FDA-approved to treat moderate to severe acute pain, which is usually caused by injury, trauma or surgery. Pain is registered in your body through nerve endings, which carry a signal to ...

Journavx (suzetrigine), a non-opioid pill for moderate-to-severe acute pain ... It works by stopping nerve cells from sending pain signals to the brain. Unlike oxycodone and other opioids ...

"The cold air outside combined with dry indoor heat sap moisture from your skin, creating tiny cracks in the barrier that expose nerve endings and cause winter's itch," explains Gohara. She says she ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

Patients might experience weakness, loss of balance and coordination, numbness or tingling WEDNESDAY, Jan. 29, 2025 (HealthDay News) -- Four in every 10 cancer patients treated with chemotherapy ...